London's leading children's hospital and research hub
[Synopsis here]
Three pairs of conjoined twins, Olivia and Gianna in Riyadh; Mercy and Goodness in Abu Dhabi; and a fourth Filipino pair in Saudi care, have undergone or prepared for separation surgeries funded by national programs and charities. Updates show varying stages of recovery and ongoing post-operative care.
The NHS is expanding an AI-driven triage tool across app users, directing patients to the right service and reducing wait times. Trials show a 29% drop in GP phone queue lines, and the program is part of a larger £10bn tech overhaul. Safety, privacy, and digital inclusion remain priorities as the rollout reaches 200,000 patients this year and all users by 2028.
AstraZeneca has announced that Wainua, its gene-silencer drug for transthyretin-mediated amyloid cardiomyopathy, did not meet its primary endpoint in a phase 3 trial. The news triggers a sharp stock drop and prompts investors to rethink the company’s long-term growth targets and the strength of its pipeline.
UK parents Maisie and Josh traveled with their unborn son Theo to Texas for a groundbreaking in-womb procedure to repair complex gastroschisis. The trial, led by foetal and paediatric surgeons, aims to shift treatment before birth. Theo was delivered healthy in Texas and is doing remarkably well; if successful, the UK could offer the procedure to more patients.